company

PRO CURE AS

1454 FAGERSTRAND

Return on Equity
21,37 %
Current Ratio
0,66
Debt-to-Equity Ratio
0
Key figures (NOK)2022
Revenue2 499 000
Net Income100 000
Total Assets1 534 000
Total Equity468 000
Income (NOK)2022
Revenue2 499 000
Expenditure2 373 000
Operating Profit105 000
Financial Income19 000
Financial Costs24 000
Financial Balance−5 000
Earnings Before Tax100 000
Tax0
Net Income100 000
Balance (NOK)2022
Total Fixed Assets834 000
Total Current Assets701 000
Total Assets1 534 000
Total Retained Equity338 000
Total Equity468 000
Total Long-Term Debt0
Total Current Debt1 066 000
Total Equity and Debt1 534 000
Cash flow (NOK)2022
Sales Income2 306 000
Other Income193 000
Revenue2 499 000
Cost of Goods Sold251 000
Salary Costs1 278 000
Depreciation179 000
Impairment0
Expenditure2 373 000
Operating Profit105 000
Financial Income19 000
Financial Costs24 000
Financial Balance−5 000
Dividends0
Net Income100 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures837 000
Total Tangible Assets837 000
Total Fiancial Fixed Assets−3 000
Total Fixed Assets834 000
Stock50 000
Total Investments169 000
Cash, Bank324 000
Total Current Assets701 000
Total Assets1 534 000
Total Equity468 000
Short-Term Group Debt0
Total Long-Term Debt0
Creditors70 000
Unpaid Taxes169 000
Dividends0
Other Current Debt123 000
Total Current Debt1 066 000
Total Equity and Debt1 534 000
Financial indicators2022
Return on Equity21,37 %
Debt-to-Equity Ratio0
Operating Profit Margin4,2 %
Current Ratio0,66
Quick Ratio0,69
Equity Ratio0,31
Gross Profit Margin89,96 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English